TY - JOUR
T1 - Patterns of amygdala region pathology in LATE-NC
T2 - subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies
AU - Cykowski, Matthew D.
AU - Arumanayagam, Anithachristy S.
AU - Powell, Suzanne Z.
AU - Rivera, Andreana L.
AU - Abner, Erin L.
AU - Roman, Gustavo C.
AU - Masdeu, Joseph C.
AU - Nelson, Peter T.
N1 - Funding Information:
Work was supported by a Clinician-Scientist Research Award from the Institute of Academic Medicine at the Houston Methodist Research Institute, an Investigator-initiated Research Award from the ALS Association (ALSA), and NIH/NINDS (RF1NS118584). The University of Kentucky Alzheimer’s Disease Research Center is supported by NIH/NIA P30AG072946. Additional support provided by NIH/NIA (R01 AG061111) and NIH/NIA (R01 AG057187).
Funding Information:
We are grateful to the study participants and families who made this research possible. We appreciate the excellent technical work provided by the personnel of the autopsy and laboratory divisions in the Department of Pathology and Genomic Medicine at Houston Methodist and the University of Kentucky Alzheimer?s Disease Research Center. We thank Dr. Dennis Dickson (Mayo Clinic, Jacksonville, Florida), who suggested the use of CD44 staining for process predominant cases in Pattern 4.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/5
Y1 - 2022/5
N2 - Transactive response (TAR) DNA-binding protein 43 kDa (TDP-43) pathology is a hallmark of limbic-predominant age-related TDP-43 encephalopathy (LATE). The amygdala is affected early in the evolution of LATE neuropathologic change (LATE-NC), and heterogeneity of LATE-NC in amygdala has previously been observed. However, much remains to be learned about how LATE-NC originates and progresses in the brain. To address this, we assessed TDP-43 and other pathologies in the amygdala region of 184 autopsied subjects (median age = 85 years), blinded to clinical diagnoses, other neuropathologic diagnoses, and risk genotype information. As previously described, LATE-NC was associated with older age at death, cognitive impairment, and the TMEM106B risk allele. Pathologically, LATE-NC was associated with comorbid hippocampal sclerosis (HS), myelin loss, and vascular disease in white matter (WM). Unbiased hierarchical clustering of TDP-43 inclusion morphologies revealed discernable subtypes of LATE-NC with distinct clinical, genetic, and pathologic associations. The most common patterns were: Pattern 1, with lamina II TDP-43 + processes and preinclusion pathology in cortices of the amygdala region, and frequent LATE-NC Stage 3 with HS; Pattern 2, previously described as type-β, with neurofibrillary tangle-like TDP-43 neuronal cytoplasmic inclusions (NCIs), high Alzheimer’s disease neuropathologic change (ADNC), frequent APOE ε4, and usually LATE-NC Stage 2; Pattern 3, with round NCIs and thick neurites in amygdala, younger age at death, and often comorbid Lewy body disease; and Pattern 4 (the most common pattern), with tortuous TDP-43 processes in subpial and WM regions, low ADNC, rare HS, and lower dementia probability. TDP-43 pathology with features of patterns 1 and 2 were often comorbid in the same brains. Early and mild TDP-43 pathology was often best described to be localized in the “amygdala region” rather than the amygdala proper. There were also important shared attributes across patterns. For example, all four patterns were associated with the TMEM106B risk allele. Each pattern also demonstrated the potential to progress to higher LATE-NC stages with confluent anatomical and pathological patterns, and to contribute to dementia. Although LATE-NC showed distinct patterns of initiation in amygdala region, there was also apparent shared genetic risk and convergent pathways of clinico-pathological evolution.
AB - Transactive response (TAR) DNA-binding protein 43 kDa (TDP-43) pathology is a hallmark of limbic-predominant age-related TDP-43 encephalopathy (LATE). The amygdala is affected early in the evolution of LATE neuropathologic change (LATE-NC), and heterogeneity of LATE-NC in amygdala has previously been observed. However, much remains to be learned about how LATE-NC originates and progresses in the brain. To address this, we assessed TDP-43 and other pathologies in the amygdala region of 184 autopsied subjects (median age = 85 years), blinded to clinical diagnoses, other neuropathologic diagnoses, and risk genotype information. As previously described, LATE-NC was associated with older age at death, cognitive impairment, and the TMEM106B risk allele. Pathologically, LATE-NC was associated with comorbid hippocampal sclerosis (HS), myelin loss, and vascular disease in white matter (WM). Unbiased hierarchical clustering of TDP-43 inclusion morphologies revealed discernable subtypes of LATE-NC with distinct clinical, genetic, and pathologic associations. The most common patterns were: Pattern 1, with lamina II TDP-43 + processes and preinclusion pathology in cortices of the amygdala region, and frequent LATE-NC Stage 3 with HS; Pattern 2, previously described as type-β, with neurofibrillary tangle-like TDP-43 neuronal cytoplasmic inclusions (NCIs), high Alzheimer’s disease neuropathologic change (ADNC), frequent APOE ε4, and usually LATE-NC Stage 2; Pattern 3, with round NCIs and thick neurites in amygdala, younger age at death, and often comorbid Lewy body disease; and Pattern 4 (the most common pattern), with tortuous TDP-43 processes in subpial and WM regions, low ADNC, rare HS, and lower dementia probability. TDP-43 pathology with features of patterns 1 and 2 were often comorbid in the same brains. Early and mild TDP-43 pathology was often best described to be localized in the “amygdala region” rather than the amygdala proper. There were also important shared attributes across patterns. For example, all four patterns were associated with the TMEM106B risk allele. Each pattern also demonstrated the potential to progress to higher LATE-NC stages with confluent anatomical and pathological patterns, and to contribute to dementia. Although LATE-NC showed distinct patterns of initiation in amygdala region, there was also apparent shared genetic risk and convergent pathways of clinico-pathological evolution.
KW - DLB
KW - GRN
KW - Lewy
KW - Neuropathology
KW - Nondemented
KW - PART
KW - Preclinical
KW - Tauopathy
KW - Humans
KW - Risk Factors
KW - Amygdala/metabolism
KW - Nerve Tissue Proteins/metabolism
KW - Membrane Proteins/metabolism
KW - DNA-Binding Proteins/genetics
KW - Aged, 80 and over
KW - Alzheimer Disease/pathology
UR - http://www.scopus.com/inward/record.url?scp=85127601232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127601232&partnerID=8YFLogxK
U2 - 10.1007/s00401-022-02416-5
DO - 10.1007/s00401-022-02416-5
M3 - Article
C2 - 35366087
AN - SCOPUS:85127601232
SN - 0001-6322
VL - 143
SP - 531
EP - 545
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 5
ER -